JP2018531977A - 免疫機能を調節するため及び腸の炎症を治療するためのベータ−１，３−グルカンの使用 - Google Patents

免疫機能を調節するため及び腸の炎症を治療するためのベータ−１，３−グルカンの使用 Download PDF

Info

Publication number
JP2018531977A
JP2018531977A JP2018522054A JP2018522054A JP2018531977A JP 2018531977 A JP2018531977 A JP 2018531977A JP 2018522054 A JP2018522054 A JP 2018522054A JP 2018522054 A JP2018522054 A JP 2018522054A JP 2018531977 A JP2018531977 A JP 2018531977A
Authority
JP
Japan
Prior art keywords
beta
glucan
euglena
disease
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2018522054A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018531977A5 (cg-RX-API-DMAC7.html
Inventor
ホルスト，ジェフリー・ポール
レヴィーン，ロバート・バーナード
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kemin Industries Inc
Original Assignee
Kemin Industries Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemin Industries Inc filed Critical Kemin Industries Inc
Publication of JP2018531977A publication Critical patent/JP2018531977A/ja
Publication of JP2018531977A5 publication Critical patent/JP2018531977A5/ja
Priority to JP2021076044A priority Critical patent/JP2021120383A/ja
Priority to JP2023004461A priority patent/JP2023052414A/ja
Priority to JP2024231917A priority patent/JP2025060946A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/30—Zinc; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/68—Protozoa, e.g. flagella, amoebas, sporozoans, plasmodium or toxoplasma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Mycology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2018522054A 2015-10-28 2016-10-27 免疫機能を調節するため及び腸の炎症を治療するためのベータ−１，３−グルカンの使用 Withdrawn JP2018531977A (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
JP2021076044A JP2021120383A (ja) 2015-10-28 2021-04-28 免疫機能を調節するため及び腸の炎症を治療するためのベータ−１，３−グルカンの使用
JP2023004461A JP2023052414A (ja) 2015-10-28 2023-01-16 免疫機能を調節するため及び腸の炎症を治療するためのベータ－１，３－グルカンの使用
JP2024231917A JP2025060946A (ja) 2015-10-28 2024-12-27 免疫機能を調節するため及び腸の炎症を治療するためのベータ－１，３－グルカンの使用

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562247629P 2015-10-28 2015-10-28
US62/247,629 2015-10-28
US201662305875P 2016-03-09 2016-03-09
US62/305,875 2016-03-09
PCT/US2016/059192 WO2017075262A1 (en) 2015-10-28 2016-10-27 Use of beta-1,3-glucan for modulating immune function and treating intestinal inflammation

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021076044A Division JP2021120383A (ja) 2015-10-28 2021-04-28 免疫機能を調節するため及び腸の炎症を治療するためのベータ−１，３−グルカンの使用

Publications (2)

Publication Number Publication Date
JP2018531977A true JP2018531977A (ja) 2018-11-01
JP2018531977A5 JP2018531977A5 (cg-RX-API-DMAC7.html) 2019-06-20

Family

ID=58631194

Family Applications (4)

Application Number Title Priority Date Filing Date
JP2018522054A Withdrawn JP2018531977A (ja) 2015-10-28 2016-10-27 免疫機能を調節するため及び腸の炎症を治療するためのベータ−１，３−グルカンの使用
JP2021076044A Pending JP2021120383A (ja) 2015-10-28 2021-04-28 免疫機能を調節するため及び腸の炎症を治療するためのベータ−１，３−グルカンの使用
JP2023004461A Pending JP2023052414A (ja) 2015-10-28 2023-01-16 免疫機能を調節するため及び腸の炎症を治療するためのベータ－１，３－グルカンの使用
JP2024231917A Pending JP2025060946A (ja) 2015-10-28 2024-12-27 免疫機能を調節するため及び腸の炎症を治療するためのベータ－１，３－グルカンの使用

Family Applications After (3)

Application Number Title Priority Date Filing Date
JP2021076044A Pending JP2021120383A (ja) 2015-10-28 2021-04-28 免疫機能を調節するため及び腸の炎症を治療するためのベータ−１，３−グルカンの使用
JP2023004461A Pending JP2023052414A (ja) 2015-10-28 2023-01-16 免疫機能を調節するため及び腸の炎症を治療するためのベータ－１，３－グルカンの使用
JP2024231917A Pending JP2025060946A (ja) 2015-10-28 2024-12-27 免疫機能を調節するため及び腸の炎症を治療するためのベータ－１，３－グルカンの使用

Country Status (6)

Country Link
US (3) US10912794B2 (cg-RX-API-DMAC7.html)
EP (1) EP3368049A4 (cg-RX-API-DMAC7.html)
JP (4) JP2018531977A (cg-RX-API-DMAC7.html)
CN (2) CN108430479A (cg-RX-API-DMAC7.html)
AU (1) AU2016344136B2 (cg-RX-API-DMAC7.html)
WO (1) WO2017075262A1 (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022119581A (ja) * 2021-02-04 2022-08-17 株式会社神鋼環境ソリューション 細胞間接着保護剤
JP2023543917A (ja) * 2020-10-02 2023-10-18 ドクトア クルト ヴォルフ ゲーエムベーハー ウント コンパニー カーゲー 毛髪、頭皮および皮膚の処置組成物

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3368049A4 (en) * 2015-10-28 2019-07-03 Kemin Industries, Inc. USE OF BETA-1,3-GLUCAN FOR MODULATING THE IMMUNE FUNCTION AND TREATING A DARM IGNITION
WO2018222581A1 (en) * 2017-05-29 2018-12-06 Resinnate Therapeutics Llc Methods and formulations for administering beta glucan
JP7013754B2 (ja) * 2017-09-15 2022-02-01 株式会社三洋物産 遊技機
JP7013753B2 (ja) * 2017-09-15 2022-02-01 株式会社三洋物産 遊技機
JP7120561B2 (ja) * 2017-12-04 2022-08-17 国立研究開発法人産業技術総合研究所 糖及び／又は脂質の代謝改善剤
JP7162542B2 (ja) * 2018-01-25 2022-10-28 株式会社ユーグレナ 食品因子センシング関連遺伝子発現促進用食品組成物及び食品因子センシング関連遺伝子発現促進剤
CN110115328A (zh) * 2018-02-06 2019-08-13 美国朗智生物科技集团 一种含有眼虫藻、姜黄和天然菊粉的饮料及其制备方法
CN112076208A (zh) * 2019-06-13 2020-12-15 青岛海洋生物医药研究院股份有限公司 一种葡聚糖在制备药物的应用
CN112076209A (zh) * 2019-06-14 2020-12-15 青岛海洋生物医药研究院股份有限公司 一种β-葡聚糖组合物及其用途
KR102801517B1 (ko) * 2020-02-19 2025-04-25 케민 인더스트리즈, 인코포레이티드 용해성 베타 글루칸의 조성물 및 관련 방법
CN111544592B (zh) * 2020-03-13 2022-05-03 中山大学附属第一医院 模式识别受体Dectin-1抑制剂对受体移植物的免疫保护及诱导免疫耐受的应用
JP2021079226A (ja) * 2021-03-01 2021-05-27 株式会社三洋物産 遊技機
KR102789389B1 (ko) * 2022-01-04 2025-04-04 전남대학교 산학협력단 베타글루칸 가수분해물을 포함하는 면역 기능 증진용 식품 조성물 및 이의 제조 방법
CN114668816B (zh) * 2022-02-23 2023-06-23 如新(中国)日用保健品有限公司 一种含铁皮石斛提取物的组合物及其应用
CN115746163A (zh) * 2022-11-07 2023-03-07 中国海洋大学 一种硫酸化β-葡聚糖、制备方法及其在免疫保护及抗肿瘤药物中的应用
CN117467722B (zh) * 2023-11-01 2025-02-11 武汉诺见生物技术有限公司 一种从酿酒酵母细胞发酵液中提纯β-1,3-葡聚糖的新工艺
WO2025138017A1 (zh) * 2023-12-28 2025-07-03 清华大学 昆布及其活性成分在制备治疗高果糖促进的结肠炎相关结直肠癌的药物中的应用
CN120531129A (zh) * 2024-02-22 2025-08-26 嘉兴泽元生物制品有限责任公司 一种裸藻及其产物在改善高尿酸血症中的应用

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002098433A1 (en) * 2001-06-01 2002-12-12 Ajinomoto Co., Inc. Drugs for intestinal diseases
JP2009062337A (ja) * 2007-09-07 2009-03-26 Euglena Co Ltd α−グルコシダーゼ活性阻害剤及びこれを含む食品
JP2011503161A (ja) * 2007-11-13 2011-01-27 バイオテック・ファルマコン・アーエスアー 腸管の炎症性疾患を処置または予防する方法
JP2011178700A (ja) * 2010-02-26 2011-09-15 Toyo Shinyaku Co Ltd 錠剤および錠剤製造方法
JP2013075869A (ja) * 2011-09-30 2013-04-25 Euglena Co Ltd 大腸癌抑制物質
US20130216586A1 (en) * 2012-02-22 2013-08-22 Algal Scientific Corporation Animal feed compositions and methods of using the same
JP2014118374A (ja) * 2012-12-14 2014-06-30 Euglena Co Ltd 糖尿病抑制剤
WO2015156339A1 (ja) * 2014-04-08 2015-10-15 株式会社ユーグレナ 免疫バランス調整剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006506464A (ja) * 2002-07-23 2006-02-23 ニュートリノヴァ ニュートリション スペシャリティーズ アンド フード イングリーディエンツ ゲゼルシャフト ミット ベシュレンクテル ハフツング 食事性繊維およびコレステロール低下物質で造られたコレステロール低下剤
US20050271613A1 (en) * 2004-03-29 2005-12-08 Toshio Suzuki Beta-1, 3-1, 6-D-glucan and its use
CN1759834B (zh) * 2004-09-17 2010-06-23 中国医学科学院医药生物技术研究所 黄连素或其与辛伐他汀联合在制备用于预防或治疗与血脂有关疾病或症状的产品中用途
US20100093658A1 (en) * 2006-01-06 2010-04-15 Sapporo Breweries Limited Therapeutic Agent For Metabolic Syndrome and Food Containing the Therapeutic Agent
US8084065B2 (en) 2006-05-29 2011-12-27 Fenchem Enterprises, Ltd Compositions for treating and preventing hyperlipidemia
BR112014027989A2 (pt) 2012-05-07 2017-07-18 Algal Scient Corporation processo multi-etapas para produção de modulador imunológico
JP2014193154A (ja) * 2013-02-28 2014-10-09 Euglena Co Ltd ユーグレナの形質転換体
US20150181909A1 (en) 2013-12-26 2015-07-02 Algal Scientific Corporation Method for improving feed efficiency and increasing growth rates in animals
EP3368049A4 (en) * 2015-10-28 2019-07-03 Kemin Industries, Inc. USE OF BETA-1,3-GLUCAN FOR MODULATING THE IMMUNE FUNCTION AND TREATING A DARM IGNITION

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002098433A1 (en) * 2001-06-01 2002-12-12 Ajinomoto Co., Inc. Drugs for intestinal diseases
JP2009062337A (ja) * 2007-09-07 2009-03-26 Euglena Co Ltd α−グルコシダーゼ活性阻害剤及びこれを含む食品
JP2011503161A (ja) * 2007-11-13 2011-01-27 バイオテック・ファルマコン・アーエスアー 腸管の炎症性疾患を処置または予防する方法
JP2011178700A (ja) * 2010-02-26 2011-09-15 Toyo Shinyaku Co Ltd 錠剤および錠剤製造方法
JP2013075869A (ja) * 2011-09-30 2013-04-25 Euglena Co Ltd 大腸癌抑制物質
US20130216586A1 (en) * 2012-02-22 2013-08-22 Algal Scientific Corporation Animal feed compositions and methods of using the same
JP2014118374A (ja) * 2012-12-14 2014-06-30 Euglena Co Ltd 糖尿病抑制剤
WO2015156339A1 (ja) * 2014-04-08 2015-10-15 株式会社ユーグレナ 免疫バランス調整剤

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
朝山雄太ほか: "ユーグレナの栄養特性と機能性", ジャパンフードサイエンス, vol. 7, JPN6020012220, 2012, pages 28 - 34, ISSN: 0004419909 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2023543917A (ja) * 2020-10-02 2023-10-18 ドクトア クルト ヴォルフ ゲーエムベーハー ウント コンパニー カーゲー 毛髪、頭皮および皮膚の処置組成物
JP2022119581A (ja) * 2021-02-04 2022-08-17 株式会社神鋼環境ソリューション 細胞間接着保護剤
JP7813518B2 (ja) 2021-02-04 2026-02-13 株式会社神鋼環境ソリューション 細胞間接着保護剤

Also Published As

Publication number Publication date
JP2025060946A (ja) 2025-04-10
EP3368049A4 (en) 2019-07-03
CA3003330A1 (en) 2017-05-04
US20180311271A1 (en) 2018-11-01
BR112018008401A2 (pt) 2018-10-23
AU2016344136B2 (en) 2021-11-11
US11744847B2 (en) 2023-09-05
EP3368049A1 (en) 2018-09-05
CN108430479A (zh) 2018-08-21
WO2017075262A1 (en) 2017-05-04
JP2021120383A (ja) 2021-08-19
AU2016344136A1 (en) 2018-05-10
CN116440154A (zh) 2023-07-18
US10912794B2 (en) 2021-02-09
US20210346423A1 (en) 2021-11-11
US20240000825A1 (en) 2024-01-04
JP2023052414A (ja) 2023-04-11

Similar Documents

Publication Publication Date Title
US11744847B2 (en) Use of beta-1,3-glucan for modulating immune function and treating intestinal inflammation
Chen et al. Polysaccharide from natural Cordyceps sinensis ameliorated intestinal injury and enhanced antioxidant activity in immunosuppressed mice
Fan et al. Protective properties of combined fungal polysaccharides from Cordyceps sinensis and Ganoderma atrum on colon immune dysfunction
FR2962045A1 (fr) Complexe macromoleculaire d'origine bacterienne et utilisation dudit complexe moleculaire pour prevenir et traiter les rhumatismes inflammatoires
CN106163533A (zh) 免疫平衡调节剂
US20170290853A1 (en) Methods to facilitate the solubilization of beta-1,3-glucan and enhance immune function and other related uses
CN107802642A (zh) 一种含有铝碳酸镁的药物组合物及制药用途
JP3829107B2 (ja) 免疫反応性ＮＯ合成を誘導するｉＮＯＳ酵素を刺激する組成剤およびその製造方法
CN107405368A (zh) 类风湿性关节炎抑制剂、类风湿性关节炎预防剂、类风湿性关节炎治疗剂及类风湿性关节炎抑制用食品
JP2018070568A (ja) 非アルコール性脂肪性肝疾患治療又は予防剤及び非アルコール性脂肪性肝疾患予防用食品
CA3003330C (en) Use of beta-1,3-glucan for modulating immune function and treating intestinal inflammation
DK2865278T3 (en) Binder fat obtained from biomass, derived from beer production
JP2024091204A (ja) 免疫機能の維持又は改善用組成物
JP2018050488A (ja) 免疫賦活用組成物
WO2021152400A1 (en) Compositions comprising pig stomach mucins and uses thereof
BR112018008401B1 (pt) Uso de uma composição
JP4954295B2 (ja) アラザイムを有効成分とする肝機能保護用薬学的組成物
WO2025078537A1 (en) Compositions comprising branched (1,3)(1,6)-beta-glucans for use in the treatment of cancer
EP4094590A1 (en) Methods and compositions using combinations of lactobacillus mucosae and soluble dietary fiber
CN117919270A (zh) 口服透明质酸及其盐在缓解急性炎症或急性炎症引起肠道损伤中的应用
JP2006001922A (ja) アレルギー抑制組成物
CN117462690A (zh) 一种药物组合物及其应用
KR20160130126A (ko) 관절염 예방 및 치료 효과를 갖는 아이디-씨비티5101(id-cbt5101) 및 이의 용도

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190515

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190515

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20200309

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200330

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20200629

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200827

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20210104

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20210430